Scientific deep-dive
Nutrition Drinks Alongside a GLP-1
A real-world study associated nutrition drinks with more fat loss and a better fat-to-lean ratio. The strongest effects were among people who complied, which is a compliance finding wearing a product's clothes.
Oral nutritional supplements, the protein-and-micronutrient drinks sold in every pharmacy, are increasingly marketed to people on GLP-1 drugs. A real-world study found their users lost more weight and more fat, with a better fat-to-lean ratio.[1] The strongest effects appeared among compliers, and that word is doing more work than the product is.
What was observed
| Measure | Difference associated with ONS use |
|---|---|
| BMI | −1.4 kg/m² |
| Body fat | −8.4 lb |
| Total weight | −10.1 lb |
| Body fat ratio | −2 percentage points |
| Lean body mass | −5.5 lb (also lost) |
| Fat-to-lean loss ratio | 2.3 (favorable) |
Effects were strongest among people under 50, those who complied with the supplement, those treated for 181 to 365 days, and those without diabetes.[1]
Why the compliance subgroup is the tell
“The effect was strongest among people who actually took the supplement” sounds like a demonstration that the supplement works. It is at least as consistent with something duller: people who reliably take a supplement are people who reliably do things.
Compliance is a personality trait before it is a product outcome.
Someone who is prescribed nutritional drinks, remembers them daily, and keeps it up for months is also more likely to attend appointments, fill prescriptions on time, escalate their dose on schedule, and exercise. Every one of those independently predicts better results. Dose escalation in particular, which we found most people never complete, is a large determinant of outcome on its own.
This is an observational comparison from a single clinic’s records: of 252 patients, 88 who were prescribed the drinks were matched with 32 who were not.[1] The drinks were prescribed only to people diagnosed with protein malnutrition, so the two groups differed before treatment began. The authors note that matching may not fully balance nutritional status between them, and no statistical adjustment fully removes a difference like that.
What is plausibly real underneath it
There may well be something here, and it is not exotic. These drinks deliver protein and micronutrients in a form that requires no appetite, no cooking and no chewing, which is a real advantage when a drug has removed the desire to eat.
The targets themselves are established: at least 1.2 g of protein per kilogram daily, and a panel of micronutrients worth monitoring, both covered in protein targets and the lab panel. A drink that helps someone reach those is doing something useful. So is chicken.
- The mechanism on offer is protein and micronutrients, not a property of the format.
- Food does the same job and costs less, for anyone who can manage it.
- The case for a drink is practical: low appetite, nausea, or no time, which are the conditions where liquid beats a plate.
- The intervention with randomized support is resistance training, covered in lean mass, drug versus dieting. No supplement has that behind it.
Frequently Asked Questions
References
- 1.Hong K, Sulo S, Wang W, et al. Oral Nutritional Supplements and Body Composition Outcomes Among GLP-1 Receptor Agonist Users: Real-World Evidence Diabetes, Metabolic Syndrome and Obesity. 2026. PMID: 42117035.
Compare the sellers
Related research
Plant-Based Protein on a GLP-1: What Closes the Gap, and Why the Drug Widens It
Across a full day at high protein intake a vegan diet matched an omnivorous one for muscle. Per meal, an omnivorous meal produced about 47% more muscle protein synthesis than a vegan one, and a GLP-1 works against the intake that closes the gap.
7 min read
Protein Targets and the Lab Panel
At least 1.2 g of protein per kg daily, 0.3–0.4 g/kg per meal, and a short lab panel: vitamin D, B12, iron studies, folate and zinc, plus thiamin in high-risk patients. The upper protein target excludes chronic kidney disease.
5 min read
Creatine on a GLP-1: The Trial Nobody Has Run
No completed trial has tested creatine in people taking a GLP‑1. The 2026 review of lean-mass preservation classes it as indirect evidence, and the lean-mass number most often quoted for it is one creatine inflates.
6 min read
The Diet Advice Nobody Has Tested
Everyone on these drugs is told to hit a protein target, drink more, add fiber. A review of 16 randomized trials of these drugs given alongside dietary guidance concluded that evidence on the optimal nutritional approach remains limited.
7 min read
Capsaicin and Capsinoids for Weight Loss: Eight Measures, Eight Nulls
A dose-response meta-analysis of 13 randomized trials and 838 participants found no effect of capsinoids on body weight, BMI, waist circumference, fat mass, fat-free mass, waist-hip ratio, visceral fat or body fat percentage.
5 min read
GLP-1s During Ramadan: What the Four Studies Actually Tested
Four studies exist on taking a GLP‑1 through Ramadan and all four enrolled people with type 2 diabetes. Both randomized trials compared against a sulfonylurea, a drug class whose defining hazard is low blood sugar.
7 min read
Where to get GLP-1 online, safely: sellers our editors have checked
These are telehealth sellers our editors have checked. For each one we hold a price, the form the drug comes in, and the states it reaches.
No insurance needed · vetted by our editors
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Collective
Flat any-dose pricing, if you can absorb a $199 annual membership on top
From $59/mo + membership
Get started →Embody
A flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies
From $79/mo
Get started →Bodybuilding Health+
Seeing what it charges before you answer any medical questions
From $179/mo
Get started →